Compare STOK & INOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STOK | INOD |
|---|---|---|
| Founded | 2014 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.8B |
| IPO Year | 2019 | 1993 |
| Metric | STOK | INOD |
|---|---|---|
| Price | $30.65 | $57.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 3 |
| Target Price | $31.00 | ★ $91.67 |
| AVG Volume (30 Days) | 1.2M | ★ 1.5M |
| Earning Date | 11-04-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 62.46 |
| EPS | 0.68 | ★ 1.01 |
| Revenue | $205,632,000.00 | ★ $238,467,000.00 |
| Revenue This Year | $416.54 | $48.07 |
| Revenue Next Year | N/A | $24.55 |
| P/E Ratio | ★ $45.14 | $56.93 |
| Revenue Growth | ★ 1128.17 | 73.57 |
| 52 Week Low | $5.35 | $26.41 |
| 52 Week High | $38.69 | $93.85 |
| Indicator | STOK | INOD |
|---|---|---|
| Relative Strength Index (RSI) | 60.05 | 41.54 |
| Support Level | $28.51 | $49.71 |
| Resistance Level | $29.38 | $57.30 |
| Average True Range (ATR) | 1.99 | 4.21 |
| MACD | 0.55 | 0.03 |
| Stochastic Oscillator | 93.67 | 32.34 |
Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.
Innodata Inc is a data engineering company. It is helping companies deploy and integrate AI into their operations and products and providing AI-enabled industry platforms. The Company's operations are classified in three reporting segments: Digital Data Solutions (DDS), Synodex and Agility. Key revenue is generated from DDS segment provides AI data preparation services, collecting or creating training data, annotating training data, and training AI algorithms for its customers, and AI model deployment and integration. It also provides a range of data engineering support services including data transformation, data curation, data hygiene, data consolidation, data extraction, data compliance, and master data management.